Renee Wegrzyn, director of the Advanced Research Projects Agency for Health, is calling on the private investment community ...

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

DexCom's Q3 results showed disappointing 2% revenue growth and a 26% decline in operating income. Click here to read my DXCM ...

The UK public body has urged the use of the Manchester developed TriageHF Plus after research found it cut hospitalisations ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to ...

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s ...

Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

Piper Sandler analyst Matthew O’Brien maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of ...

Needham analyst Michael Matson has maintained their neutral stance on MDT stock, giving a Hold rating today. Michael Matson’s rating is ...

Beese Fulmer Investment Management Inc. cut its position in Medtronic plc (NYSE:MDT – Free Report) by 24.4% during the third ...